Drug Trial Radar · NCT06422689
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,511
Actual
Start
May 10, 2024
Primary completion
Feb 3, 2027
Study completion Feb 3, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Premier HealthCare Solutions Inc.
- First posted
- May 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ANCHOR is a prospective, phase IV, interventional, single-arm, open-label study of 1,500 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare the asthma exacerbation rates before and after switching from albuterol or levalbuterol to albuterol plus budesonide inhalation aerosol as rescue therapy.
Conditions
- Asthma
Interventions
Albuterol and budesonide inhalation aerosolDrug
Participants will receive a fixed-dose combination of albuterol (90mcg) and budesonide (80mcg) administered as 2 inhalations (180mcg/160mcg) via pressurized metered dose inhaler (pMDI) as needed for asthma symptoms, for up to 12 inhalations (6 doses) in a 24-hour period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asthma exacerbationTime frame: During 12-month pre-switch and 12-month post-switch periods
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Research Site
North Hollywood, California
Research Site
Walnut Creek, California
Research Site
Louisville, Kentucky
Research Site
Boston, Massachusetts
Research Site
Ann Arbor, Michigan
Research Site
Flint, Michigan
Research Site
Minneapolis, Minnesota
Research Site
Asheville, North Carolina
Research Site
Greenville, North Carolina
Research Site
DuBois, Pennsylvania
Research Site
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.